Francisco Arancibia
Impact in
-
- Nosocomial Infections in ICU
-
- Tracheal and airway disorders
- Lung Cancer Diagnosis and Treatment
- Pleural and Pulmonary Diseases
- Chronic Obstructive Pulmonary Disease (COPD) Research
Papers in
-
- Nosocomial Infections in ICU 1
- Intensive Care Unit Cognitive Disorders 1
-
- Lung Cancer Diagnosis and Treatment 1
- Cystic Fibrosis Research Advances 1
- Co-authors
- Antoní Torres (1 shared paper)J. Angrill (1 shared paper)J. González (1 shared paper)M. Ioanas (1 shared paper)Torsten Bauer (1 shared paper)Julio Osorio (1 shared paper)Aurelio Rodríguez (1 shared paper)Claudia Valenzuela (1 shared paper)
- Partner nations
- United KingdomGuatemalaGreece
In The Last Decade
Francisco Arancibia
4 papers receiving 42 citations
Peers
Comparison fields: 5 of 23
- Critical Care and Intensive Care Medicine 10
- Pulmonary and Respiratory Medicine 30
- Endocrinology 3
- Emergency Medical Services 4
- Applied Microbiology and Biotechnology 1
Countries citing papers authored by Francisco Arancibia
This map shows the geographic impact of Francisco Arancibia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francisco Arancibia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francisco Arancibia more than expected).
Fields of papers citing papers by Francisco Arancibia
This network shows the impact of papers produced by Francisco Arancibia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francisco Arancibia. The network helps show where Francisco Arancibia may publish in the future.
Co-authors
The 18 scholars most cited alongside Francisco Arancibia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 38 | |
| 2 | 2004 | 2 | |
| 3 | 2024 | 1 | |
| 4 | Neumoperitoneo en la evolución de un paciente sometido a cirugía cardiovascular | 2011 | 1 |
About Francisco Arancibia
Francisco Arancibia is a scholar working on Critical Care and Intensive Care Medicine, Pulmonary and Respiratory Medicine, Infectious Diseases, Surgery and Neurology, having authored 4 papers that have together received 42 indexed citations. Recurring topics across this work include Long-Term Effects of COVID-19 (1 paper), Lung Cancer Diagnosis and Treatment (1 paper), Cystic Fibrosis Research Advances (1 paper), Nosocomial Infections in ICU (1 paper), Abdominal vascular conditions and treatments (1 paper), COVID-19 Clinical Research Studies (1 paper), Vascular anomalies and interventions (1 paper) and Intensive Care Unit Cognitive Disorders (1 paper). The work is most often cited by research in Critical Care and Intensive Care Medicine (10 citations), Pulmonary and Respiratory Medicine (30 citations), Endocrinology (3 citations), Emergency Medical Services (4 citations) and Applied Microbiology and Biotechnology (1 citation). Francisco Arancibia has collaborated with scholars based in United Kingdom, Guatemala and Greece. Frequent co-authors include Antoní Torres, J. Angrill, J. González, M. Ioanas, Torsten Bauer, Julio Osorio, Aurelio Rodríguez, Claudia Valenzuela, James D. Chalmers and Yuanlin Song. Their work appears in journals such as European Respiratory Journal, ERJ Open Research and CHEST Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.